The Samuel Bakhoum Lab

Share
Print
Samuel Bakhoum Lab Group

The Bakhoum lab focuses on understanding the role of chromosomal instability (CIN) in tumor evolution. CIN is a hallmark of human cancer and it is associated with poor prognosis, metastasis, and therapeutic resistance. It results from errors in chromosome segregation during mitosis, leading to structural and numerical chromosomal abnormalities. In addition to generating genomic heterogeneity that acts as a substrate for natural selection, CIN promotes inflammatory signaling by introducing genomic double-stranded DNA into the cytosol, engaging cytosolic DNA-sensing antiviral innate immune pathways. These multipronged effects distinguish CIN as a central driver of tumor evolution and as a genomic source for the crosstalk between the tumor and its microenvironment.

Learn more
Samuel Bakhoum, MD, PhD

Samuel Bakhoum, MD, PhD

Assistant Member, Human Oncology and Pathogenesis Program; Assistant Attending, Department of Radiation Oncology

Assistant Professor

Research Focus

Physician-scientist Samuel Bakhoum studies the role of chromosomal instability in tumor evolution and metastasis.

Lab Members

Selected Achievements
  • AAAS Martin and Rose Wachtel Cancer Research Award (Honorable mention)
  • NIH Director’s Independence Award (2018-2023)
  • Josie Robertson Investigator (2018-2023)
  • Blavatnik Regional Award for Young Scientists (Finalist) (2018)
  • Tri-Institutional Breakout Prize (2018)
Read more
  • Burroughs Wellcome Fund Career Award for Medical Scientists (2018)
  • NextGen Stars, American Association for Cancer Research (AACR) (2018)
  • Breast Cancer Breakthrough Award, Department of Defense (2016)
  • ASCI/AAP Outstanding Young Investigator Award (2011)
  • Norton B. Gilula Award, the American Society for Cell Biology (2008)